AMNEAL PHARMACEUTICALS, INC. (AMRX) Operating income 2016–2025
AMNEAL PHARMACEUTICALS, INC. (AMRX) annual operating income history from SEC filings — each fiscal year as reported.
$394.1MFY2025 · since FY2016: $284.9M → $394.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $394.1M | +58.1% |
| FY2024 | $249.3M | +22.0% |
| FY2023 | $204.4M | +315.3% |
| FY2022 | -$94.9M | -162.2% |
| FY2021 | $152.7M | +67.5% |
| FY2020 | $91.2M | +136.7% |
| FY2019 | -$248.7M | -1164.1% |
| FY2018 | -$19.7M | -108.0% |
| FY2017 | $245.1M | -14.0% |
| FY2016 | $284.9M | — |
Source: SEC XBRL filings · For reference only · Not investment advice